Central Florida Technology Ventures
Central Florida Technology Ventures
info@cftechventures.com
Central Florida Technology Ventures provides seed capital to fund the growth of early-stage, high quality, technology ventures. This seed fund prefers to invest in companies commercializing technologies in the following areas: biotechnology, clean technology, electronics/instrumentation, Internet/web services, medical devices and equipment, nanotechnology, semiconductors, software, telecommunications, or wireless technologies.
The Central Florida Technology Ventures seed fund prefers to invest in companies located in or within close proximity to the 23-county Florida High Technology Corridor, which is centered in Orlando and stretches from Gainesville to Port Charlotte.
Companies that are selected to receive funding are often experienced, customer specific entities that are competitive within their market and have a prototyped product that will address a particular market niche.
They will screen your application and will inform you by phone or email if they would like to consider your company for potential inclusion in their portfolio. You should hear from them within two weeks of your submission. If they decide to move forward with due diligence on your company, they will ask for more detailed information. Those companies meeting the investment criteria and target goals will be asked to present at the next monthly fund meeting. Members will then make a decision whether to proceed with final review and investment. Their goal is to close an investment within 60 days of your submission.
The online application for the Central Florida Technology Ventures fund is available through the following through this website.
Award details are not provided.
Inflexion Fund
Jim Boyle
Managing Partner
Inflexion Partners
12565 Research Pkwy, Suite 300
Orlando, FL 32826
(407) 381-2675
jim@inflexionvc.com
Inflexion Fund is a seed/early-stage venture capital fund that invests locally and strives to develop companies on a national scale.
Investment criteria for the Inflexion Fund includes seed and early-stage companies that are often conducting business (or focusing their business efforts) within the state of Florida. There are rare and exceptional cases where the Inflexion Fund will invest in other Southeastern opportunities. Eligible companies work within the communications, software, and life science industries.
Companies interested in submitting a business plan to the Inflexion Fund may do so by visiting here.
The investment size ranges from $100,000-$1,000,000 as part of a larger round, with a reserve for future rounds.
Florida Growth Fund
Hamilton Lane Advisors, LLC
Florida Growth Fund Team
200 SW 1st Avenue
Suite 880
Fort Lauderdale, FL 33301
(954) 745-2780
floridagrowthfund@hamiltonlane.com
The Florida Growth Fund was established in 2009 to enhance Florida’s capacity for development, growth and innovation. On behalf of the Florida State Board of Administration, Hamilton Lane actively pursues private equity investment opportunities for the Florida Growth Fund. The Fund has $500 million under management. Opportunities include private equity fund investments as well as co-investments.
This fund typically invests in companies that are headquartered or based in the state of Florida, or those that demonstrate an operational presence within the state. Companies with appealing growth trends, experienced management, or those that are particularly profitable will be desirable. They specifically look for companies working within several industries including clean technology, renewable resources, biotechnology, pharmaceuticals, healthcare and healthcare services, medical and life sciences, information technology, telecommunications, and aerospace and defense technologies.
Applicants interested in co-investment opportunities from the Florida Growth Fund (managed by Hamilton Lane), private equity funds, or sponsors looking for a co-investment partner should send an email to floridagrowthfund@hamiltonlane.com.
Award details not provided.
Updated March 2018, Kristin Stiner
